We are live on ! Find out more
CSLT

CASTLIGHT HEALTH, INC.

Delisted

CSLT was delisted on the 16th of February, 2022.

112 hedge funds and large institutions have $259M invested in CASTLIGHT HEALTH, INC. in 2019 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 47 increasing their positions, 24 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

217% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 6

96% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 24

9% more funds holding

Funds holding: 103112 (+9)

9% less capital invested

Capital invested by funds: $285M → $259M (-$25.9M)

67% less funds holding in top 10

Funds holding in top 10: 31 (-2)

Holders
112
Holders Change
+9
Holders Change %
+8.74%
% of All Funds
2.43%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
19
Increased
47
Reduced
24
Closed
6
Calls
$82K
Puts
Net Calls
+$82K
Net Calls Change
-$16K
Name Holding Trade Value Shares
Change
Change in
Stake
Acadian Asset Management
26
Acadian Asset Management
Massachusetts
$1.8M +$1.04M +303,138 +119%
RHJA
27
Rice Hall James & Associates
California
$1.65M -$89.5K -25,973 -5%
Charles Schwab
28
Charles Schwab
California
$1.54M +$184K +53,485 +13%
Goldman Sachs
29
Goldman Sachs
New York
$1.47M +$874K +253,757 +126%
N
30
Nuveen
North Carolina
$1.39M +$1.48M +430,698 New
Russell Investments Group
31
Russell Investments Group
United Kingdom
$1.19M +$72.1K +20,938 +6%
Bank of New York Mellon
32
Bank of New York Mellon
New York
$1.15M +$110K +32,069 +10%
Jacobs Levy Equity Management
33
Jacobs Levy Equity Management
New Jersey
$1.15M +$1.22M +354,541 New
HP
34
Harbourvest Partners
Massachusetts
$1.13M
CC
35
Cannell Capital
Wyoming
$858K +$915K +265,543 New
PM
36
Penbrook Management
New York
$852K -$27.6K -8,000 -3%
Bank of America
37
Bank of America
North Carolina
$829K -$205K -59,473 -19%
AP
38
AlpInvest Partners
Netherlands
$752K
BCM
39
Bridgeway Capital Management
Texas
$742K -$916K -265,900 -54%
PAM
40
Panagora Asset Management
Massachusetts
$684K +$729K +211,805 New
Squarepoint
41
Squarepoint
New York
$522K +$2.99K +867 +0.5%
Millennium Management
42
Millennium Management
New York
$520K +$184K +53,347 +50%
AO
43
Allen Operations
New York
$508K
AIM
44
Alambic Investment Management
California
$501K -$278K -80,600 -34%
California State Teachers Retirement System (CalSTRS)
45
California State Teachers Retirement System (CalSTRS)
California
$501K +$120K +34,764 +29%
Two Sigma Investments
46
Two Sigma Investments
New York
$488K +$175K +50,906 +51%
Swiss National Bank
47
Swiss National Bank
Switzerland
$479K
EWM
48
Edge Wealth Management
New York
$448K +$58.5K +17,000 +14%
AllianceBernstein
49
AllianceBernstein
Tennessee
$425K +$21K +6,100 +5%
Deutsche Bank
50
Deutsche Bank
Germany
$418K -$371K -107,735 -45%

CSLT Hedge Fund Activity: Q2 2019 in Review

112 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in CASTLIGHT HEALTH, INC. (CSLT) for Q2 2019, worth a combined $259M — down 9.1% from $285M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new CSLT positions and 6 closed out — a net gain of 13 holders — while 47 added to existing stakes and 24 trimmed.

The largest buyer was BlackRock, adding an estimated $4.14M. The largest seller was Bellevue Group, cutting an estimated $3.51M.

  • 112 institutional investors held CASTLIGHT HEALTH, INC. (CSLT) as of Q2 2019, up from 103 in Q1 2019.
  • Funds reported $259M of CASTLIGHT HEALTH, INC. stock for Q2 2019, down 9.1% quarter-over-quarter.
  • 19 funds opened new CASTLIGHT HEALTH, INC. positions in Q2 2019 and 6 closed out, a net change of +13 holders.
  • The largest CASTLIGHT HEALTH, INC. buyer in Q2 2019 was BlackRock, an estimated $4.14M added.
  • The largest CASTLIGHT HEALTH, INC. seller in Q2 2019 was Bellevue Group, an estimated $3.51M sold.

Based on aggregated 13F filings for Q2 2019.